tachycardia and semaglutide Patient Basics: Can Ozempic (semaglutide) cause tachyarrhythmias?

These products are not intended to diagnose, treat, cure, or prevent any disease

I hope you will find this brief review of the peptide landscape helpful

Theyre also an opportunity to address new concerns or symptoms

Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges

(2013) How to design nutritional intervention trials to slow cognitive decline in apparently healthy populations and apply for efficacy claims: a statement from the international academy on nutrition and aging task force